Henlius’ Rituximab Results Bolster RA Ambitions In China

Reports Positive Phase III Data At National Congress Of Chinese Rheumatology

China Flag Thumbs Up
Henlius is hoping to secure Chinese approval for the RA indication • Source: Alamy

More from Biosimilars

More from Products